|
|
Volumn 3, Issue 5, 1997, Pages 506-512
|
|
Enhanced (cytomegalovirus) vital replication after transplantation for fulminant hepatic failure
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GANCICLOVIR;
TUMOR NECROSIS FACTOR ALPHA;
ARTICLE;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INFECTION RISK;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
QUANTITATIVE ASSAY;
SERODIAGNOSIS;
VIRUS ACTIVATION;
VIRUS REPLICATION;
CYTOMEGALIC INCLUSION BODY DISEASE;
CYTOMEGALOVIRUS;
ENZYME LINKED IMMUNOSORBENT ASSAY;
GRAFT REJECTION;
HEPATIC ENCEPHALOPATHY;
LEUKOCYTE;
PHYSIOLOGY;
POLYMERASE CHAIN REACTION;
PROSPECTIVE STUDY;
VIROLOGY;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GRAFT REJECTION;
HEPATIC ENCEPHALOPATHY;
HUMANS;
LEUKOCYTES;
LIVER TRANSPLANTATION;
POLYMERASE CHAIN REACTION;
PROSPECTIVE STUDIES;
TUMOR NECROSIS FACTOR-ALPHA;
VIRUS REPLICATION;
|
|
EID: 0030613516
PISSN: 10743022
EISSN: None
Source Type: Journal
DOI: 10.1002/lt.500030505 Document Type: Article |
|
Times cited : (22)
|
|
References (14)
|
